Skip to main content

Nandrolone Pregnancy and Breastfeeding Warnings

Brand names: Anabolin LA, Androlone-D, Andryl 200, Deca-Durabolin, Durabolin, Durabolin 50, Hybolin Decanoate, Hybolin-Improved

Nandrolone Pregnancy Warnings

Nandrolone has been assigned to FDA pregnancy category X by the FDA. Anabolic steroid use, particularly during the first trimester of pregnancy, may cause virilization of the external genitalia of the female fetus. Reversible oligospermia may occur after prolonged administration or excessive dosage in male patients. There are no controlled data in human pregnancy. Nandrolone is considered contraindicated during pregnancy.

If reversible oligospermia occurs, the anabolic steroid can be discontinued and if restarted, a lower dosage should be utilized.

See references

Nandrolone Breastfeeding Warnings

There are no data on the excretion of anabolic steroids into human milk. Because many drugs are excreted into human milk and because of the potential for adverse effects on the nursing infant, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the woman.

See references

References for pregnancy information

  1. (2001) "Product Information. Deca-Durabolin (nandrolone)." Organon

References for breastfeeding information

  1. (2001) "Product Information. Deca-Durabolin (nandrolone)." Organon

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.